Daratumumab, bortezomib, cyclophosphamide and dexamethasone in newly diagnosed and relapsed multiple myeloma: LYRA study

by Yimer, Habte, Melear, Jason, Faber, Edward, Bensinger, William I., Burke, John M., Narang, Mohit, Stevens, Don, Gunawardena, Sriya, Lutska, Yana, Qi, Keqin, Ukropec, Jon, Qi, Ming, Lin, Thomas S., Rifkin, Robert M.
Published in Br J Haematol (2019)

CMET-30. LEPTOMENINGEAL METASTASES: OUTCOMES WITH AGGRESSIVE MULTIMODALITY TREATMENT

by Smith, Rachel, Boman, Christina, Thatikonda, Srivani, Dziuk, Timothy, Tumu, Hari, Hellerstedt, Beth, Patt, Debra, Nuesch, Carl, Pearson, Rachel, Cohen, Karen, Kemper, Craig, Sheinbein, Courtney, Kim, Stanley, Fain, Jerry, de Celis, Carlos Rubin, Melear, Jason, Groves, Morris D
Published in Neuro Oncol (2017)

LTBK-04. PHASE 2 MULTICENTER STUDY OF THE ONCOLYTIC ADENOVIRUS DNX-2401 (TASADENOTUREV) IN COMBINATION WITH PEMBROLIZUMAB FOR RECURRENT GLIOBLASTOMA; CAPTIVE STUDY (KEYNOTE-192)

by Zadeh, Gelareh, Daras, Mariza, Cloughesy, Timothy F, Colman, Howard, Kumthekar, Priya U, Chen, Clark C, Aiken, Robert, Groves, Morris D, Ong, Shirley, Ramakrishna, Rohan, Vogelbaum, Michael A, Khagi, Simon, Kaley, Thomas, Melear, Jason M, Peereboom, David M, Rodriguez, Analiz, Yankelevich, Maxim, Nair, Suresh G, Puduvalli, Vinay K, Nassiri, Farshad, Sonabend, Adam M, Agensky, Laura, Ewald, Brett, Levisetti, Matteo, Lang, Frederick F
Published in Neuro Oncol (2020)